Additional diagnostic evaluation included testing for myelin-oligodendrocyte glycoprotein (MOG) antibodies and anti-aquaporin 4 antibodies, to rule out other demyelinating conditions, specifically MOG antibody-associated disease (MOGAD) and Neuromyelitis Optica Spectrum Disorders (NMOSD). This evidence concerns the gene MOG and neuromyelitis optica.